Showing 48 out of 58 results
Personalised Health and The Future of Pharma
Growing social and political pressures combined with disruptive technologies and scientific innovation are changing the way pharma companies do …
France adopts a confidentiality regime for the trade secrets relied upon in (patent) litigation
As part of the French Law on the Protection of Trade Secrets dated 31 July 2018, French lawmakers have finally adopted a long-awaited array of …
Patent and Pharma Update, October 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector The CJEU has provided its preliminary ruling …
Brexit “no deal” technical notices published on intellectual property and life sciences sector issues
The latest tranche of “no deal” technical notices was released yesterday afternoon by the UK Government. Amongst them are several notices that highlight …
Brexit White Paper highlights importance of Intellectual Property rights post-Brexit
Significantly, for those with interests in IP rights, the UK Government's White Paper on Brexit makes encouraging noises about future recognition and …
Patent and Pharma Update, July 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector English courts begin to consider the new …
Herbert Smith Freehills' New Milan Office Wins Another Haul of Awards
Herbert Smith Freehills Partner Laura Orlando and new recruit Senior Associate Sara Balice walked away with two prestigious accolades at the Italian …
ADVOCATE GENERAL PROVIDES OPINION ON THE INTERPRETATION OF ARTICLE 3(a) SPC REGULATION
Advocate General Wathelet (the "AG") has provided his opinion to the Court of Justice of the European Union (the "CJEU") on the interpretation of Article …
Herbert Smith Freehills Marks Milan office opening with launch party
Business leaders gathered together this week to celebrate Herbert Smith Freehills' official office opening at a party in Milan. More than 100 guests …
Arbitrating Pharma Disputes On The Rise – Planning Ahead Makes Sense
Pharmaceutical companies risk coming up against complex and high value disputes in their everyday dealings and operations, and we are increasingly seeing …
Brexit 'The view from Brussels' – developments in January
January was dominated by the strikingly public discussion of the content of the next supplement to the negotiating guidelines that the European Council …
Patent and Pharma update - November 2017
Key recent developments in the United Kingdom and Europe relating to the patents and pharmaceutical sector. One of the most significant developments in …
Showing 48 out of 58 results
View more